Rite-Aid sued for false advertising of glucosamine tablets

bouton croixA class action lawsuit has been filed in New York federal court by a Staten Island resident accusing Rite Aid Corp. of misrepresenting that its store-brand glucosamine and chondroitin supplements can “help rebuild cartilage and lubricate joints” easing the symptoms of arthritis, even though significant scientific evidence contradicts those claims.  

The complaint alleges “the bulk, if not all, of the reliable and published scientific studies demonstrate that Rite Aid’s claims are false and misleading,” claimed the plaintiff.  The lawsuit specifically points to a study by the National Institute of Health in 2006, which concluded that glucosamine and chondroitin, individually or in combination, were ineffective in treating arthritis. The plaintiff seeks to represent a class of New York State consumers who purchased Rite Aid varieties of glucosamine and chondroitin supplements.

Steve Larson

An experienced trial lawyer who handles both hourly and contingent fee cases, Steve has expertise in class actions, environmental clean-up litigation, antitrust litigation, securities litigation, corporate disputes, intellectual property disputes, unfair competition claims, and disputes involving family wealth. Steve regularly represents individuals and businesses in federal and state court and has obtained class-wide recovery in multiple class actions. A veteran practitioner, Steve’s clients value his creative approach to resolving complex litigation matters.

Share: 

Legal Disclaimer

The information contained in this blog does not constitute legal advice, and does not create an attorney-client relationship. We make no claims, promises or guarantees about the accuracy, completeness, or adequacy of the information contained in or linked to this blog.